Wai Chun Bio-Technology Limited risk profile
72 Stretched several inputs deteriorating together
Measured 21 October 2026 from 0660.HK's filed statements. Recomputed nightly.
72 (Stretched), driven by Cash conversion at 94, over 3 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | Reads pct_below_52w_high, volatility_1y_pct and avg_turnover_90d_usd. No reading is stored for this company. | |||
| Operating pressure | 57 | Elevated | Stable | Costs outgrowing revenue — +0.1 percentage points |
| Cash conversion | 94 | Acute | Worsening | Capital spending against operating cash — 18.31x |
| Leverage and coverage | 79 | Stretched | Easing | Net debt to EBITDA — 4.95x |
| Competitive position | Reads research_and_development, operating_income, revenue, peer cohort and disclosed transition KPIs. No reading is stored for this company. | |||
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.
Basic Materials companies with a risk reading
Linde Plc. 28BHP Group Ltd 24Industria De Diseno Textil SA 20Southern Copper Corporation 13Rio Tinto Group 40Rio Tinto plc 37Newmont Corp 21L'Air Liquide S.A. 39Freeport-McMoRan Inc 35Agnico Eagle Mines Ltd 10Glencore plc 62Glencore PLC 62
Financials, valuation and price history for Wai Chun Bio-Technology Limited